STRYKER CORP Derivative Liability
STRYKER CORP (SYK) had Derivative Liability of $13.00 million as of 2014-06-30, per its 10-Q filed 2014-07-24.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2014-07-24
- 2014-06-30: Derivative Liability $13.00M.
- 2014-03-31: Derivative Liability $6.00M.
- 2013-12-31: Derivative Liability $2.00M.
- 2013-09-30: Derivative Liability $1.00M.
| Period end | Derivative Liability |
|---|---|
| 2014-06-30 | $13.00M 10-Q · filed 2014-07-24 |
| 2014-03-31 | $6.00M 10-Q · filed 2014-04-24 |
| 2013-12-31 | $2.00M 10-Q · filed 2014-07-24 |
| 2013-09-30 | $1.00M 10-Q · filed 2013-10-23 |
| 2012-12-31 | $1.00M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |